No substantial benefit from transplantation reported for a highrisk leukaemia subtype

No substantial benefit from transplantation reported for a high-risk leukaemia subtype

Checking for minimal residual disease early in treatment can help some young high-risk leukaemia patients avoid bone marrow transplantation without compromising their long-term survival. A St. Jude Children's Research Hospital investigator led the...

More From BioPortfolio on "No substantial benefit from transplantation reported for a high-risk leukaemia subtype"